Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score

Abstract

We identified independent risk factors for patients treated with TACE. The newly constructed M-TACE score is superior to established staging systems and might prove helpful to identify patients who are most suitable for TACE.